These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 26313652)
1. Value of the 340B Drug Discount Program. Kantarjian H; Chapman R JAMA Oncol; 2015 Nov; 1(8):1029-30. PubMed ID: 26313652 [No Abstract] [Full Text] [Related]
3. 340B Drug Pricing Program Reform-Reply. Kantarjian H; Chapman R JAMA Oncol; 2016 Mar; 2(3):403-4. PubMed ID: 26967191 [No Abstract] [Full Text] [Related]
4. Comprehensive Legislative Reform to Protect the Integrity of the 340B Drug Discount Program. Zeta LM Food Drug Law J; 2015; 70(4):481-99, i. PubMed ID: 26827389 [TBL] [Abstract][Full Text] [Related]
5. The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012. Clark BL; Hou J; Chou CH; Huang ES; Conti R Health Aff (Millwood); 2014 Nov; 33(11):2012-7. PubMed ID: 25367997 [TBL] [Abstract][Full Text] [Related]
6. Role of the 340B Drug Discount Program in Recent Cancer Care Trends. Kantarjian HM; Chapman R J Oncol Pract; 2015 Jul; 11(4):303-7. PubMed ID: 26036268 [TBL] [Abstract][Full Text] [Related]
7. Medicaid under siege. While some aim at universal coverage, a safety net program keeps taking hits. Sloan T Mod Healthc; 2007 Mar; 37(13):18. PubMed ID: 17427887 [No Abstract] [Full Text] [Related]
8. Why California's Proposition 61 Was a Bad Idea. Yang YT; Chen B; Bennett CL Am J Med; 2017 Aug; 130(8):882-884. PubMed ID: 28454905 [No Abstract] [Full Text] [Related]
9. Access to health insurance: State Children's Health Insurance Program. Issue brief. Gibbons KH Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297472 [No Abstract] [Full Text] [Related]
10. Risks to the 340B Drug Pricing Program Related to Manufacturer Restrictions on Drug Availability. Knox RP; Kesselheim AS; Sarpatwari A JAMA; 2022 May; 327(17):1647-1648. PubMed ID: 35426909 [No Abstract] [Full Text] [Related]
11. Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door. Yang YT; Chen B; Bennett CL J Clin Oncol; 2016 Dec; 34(36):4320-4322. PubMed ID: 27998222 [No Abstract] [Full Text] [Related]
12. Increasing Medicaid fees: more than meets the eye. Casamassimo P Pediatr Dent; 2014; 36(1):10-1. PubMed ID: 24717699 [No Abstract] [Full Text] [Related]
13. The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities. Conti RM; Bach PB Health Aff (Millwood); 2014 Oct; 33(10):1786-92. PubMed ID: 25288423 [TBL] [Abstract][Full Text] [Related]
14. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations. Werling K; Abraham S; Strelec J Health Care Law Mon; 2007 Aug; ():3-12. PubMed ID: 17955590 [No Abstract] [Full Text] [Related]
15. Medicaid expansion choices mean different care for poor diabetics, depending on where they live. Page P Am J Manag Care; 2014 May; 20(8 Spec No.):E2. PubMed ID: 25617924 [No Abstract] [Full Text] [Related]
16. Ensuring access to prescription medications in the post-ACA healthcare access landscape: the essential role of FQHCs in the safety net for the underinsured. Shi L; Wharton MK; Monnette A Am J Manag Care; 2018 Mar; 24(5 Suppl):S67-S73. PubMed ID: 29620813 [TBL] [Abstract][Full Text] [Related]
17. The worsening Medicaid fiscal crisis. Implications for hospitals. Collins M; Bussard PA; Combes JR J Ambul Care Manage; 2003; 26(4):349-54. PubMed ID: 14567279 [TBL] [Abstract][Full Text] [Related]
18. Medicare savings programs: helping those on Medicare pay for health care. Reinhard SC; Scala-Foley MA; Caruso JT; Archer D Am J Nurs; 2004 Jun; 104(6):62-4. PubMed ID: 15187617 [No Abstract] [Full Text] [Related]
19. Position statement--title: Medicaid expansion in Colorado. Colo Nurse; 2013 May; 113(2):8. PubMed ID: 23795531 [No Abstract] [Full Text] [Related]